ACTIVE_NOT_RECRUITING

Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.

Official Title

Pilot Study of Episodic Future Thinking Among Cigarette Smokers

Quick Facts

Study Start:2024-09-15
Study Completion:2026-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05825001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Smoke \>= 10 cigarettes daily
  2. * \>32 on the Vividness of Visual Imagery Questionnaire (VVIQ)
  3. * No regular use of other tobacco products
  4. * In possession of a smartphone with text messaging capabilities
  5. * Willing to quit smoking in the next 30 days
  6. * Low socioeconomic status
  7. * Veteran of the US armed services
  1. * Unable or unwilling to provide verbal consent
  2. * Unable or unwilling to provide data to the research team
  3. * Current use of nicotine replacement therapy, bupropion, or varenicline
  4. * Use of drugs of abuse in the past 30 days
  5. * Living in the same household as a participant already enrolled in this study
  6. * Unable or unwilling to use nicotine patches

Contacts and Locations

Principal Investigator

Christine Sheffer
PRINCIPAL_INVESTIGATOR
Roswell Park

Study Locations (Sites)

Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Christine Sheffer, PRINCIPAL_INVESTIGATOR, Roswell Park

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-15
Study Completion Date2026-10-01

Study Record Updates

Study Start Date2024-09-15
Study Completion Date2026-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cigarette Smoking-Related Carcinoma